ATS Q2 revenue retreats to C$665.8 million
Key points
- ATS reported fiscal second-quarter 2027 revenue of C$665.8 million, down 8.6% year over year, while recording a net loss of C$5 million.
- Adjusted EBITDA declined to C$80.7 million from C$103.7 million, although order bookings increased 12.7% to C$827 million.
- ATS continued its Fixed Cost Transformation Program as management reported increased life sciences orders and a record backlog in that business.
ATS (NYSE:ATS) reported fiscal second-quarter 2027 revenue of C$665.8 million, down 8.6%, while posting a C$5 million net loss.
Revenue declined from C$728.5 million a year earlier, while earnings shifted from a C$0.34-per-share profit to a C$0.05 loss.
Adjusted EBITDA fell to C$80.7 million from C$103.7 million, while order bookings increased 12.7% to C$827 million.
ATS expects its Fixed Cost Transformation Program to improve efficiency as it addresses delayed customer investment decisions and tariff uncertainty.
Order backlog totaled C$2.009 billion, down from C$2.070 billion, although the life sciences backlog reached a company record.
Six-month revenue declined to C$1.36 billion from C$1.47 billion, while ATS continued expanding aftermarket services and restructuring selected operations.
Frequently asked questions
More from United States
LivaNova delivers Q3 revenue of $393.1M, up 9.9%
NICE reports $790.7 million in Q3 revenue, up 8%
AES revenue reaches $3.87 billion as Q3 sales accelerate
Autohome Q3 revenue slides 6% to RMB1.32 billion
Cadeler secures contract for 87 Dogger Bank turbines
Boeing finalizes Avolon order for 140 737-10 jets
